ADVERTISEMENT

India Specialty Chemicals - To Witness Healthy Growth In Medium Term, Driven By Domestic, Export Demand: ICRA

India Specialty Chemicals - To Witness Healthy Growth In Medium Term, Driven By Domestic, Export Demand: ICRA

<div class="paragraphs"><p>Vials of different coloured chemicals. (Photographer: Hannelore Foerster/Bloomberg)</p></div>
Vials of different coloured chemicals. (Photographer: Hannelore Foerster/Bloomberg)

BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.

ICRA Research Report

The credit outlook for the specialty chemical industry remains stable. The segment has not witnessed any adverse impact in FY21 due to Covid-19, except in a few segments like dyes and pigments and refrigerant segments.

The performance was supported by recovery in domestic demand from Q2 FY21 onwards, which accelerated in H2 FY21 following healthy demand from the export market.

Further, favorable raw material prices during nine months FY21 also aided the margins.

While, the revenue growth trend had continued in Q4 FY21, there was some moderation in margin due to increase in raw material prices.

Click on the attachment to read the full report:

ICRA Specialty Chemicals Sector.pdf

DISCLAIMER

This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.

Users have no license to copy, modify, or distribute the content without permission of the Original Owner.